[1]
2020. Efficacy and Safety of Tralokinumab with Concomitant Topical Corticosteroids in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of the ECZTRA 3 Trial. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s97. DOI:https://doi.org/10.25251/skin.4.supp.97.